Cardiovascular AI startup Corologic raises seed funding from Kakao Ventures and SNU Holdings to advance clinical validation and commercialization of its AngioFilm solution.
Round Type
Seed
South KoreaManufacturingBiotechnologyHealth CareArtificial IntelligenceMedical DeviceMachine LearningImage RecognitionInvestors
Description
Corologic, a cardiovascular imaging AI startup founded in May 2026, has raised seed funding from Kakao Ventures and SNU Holdings. The company will use the proceeds for multicenter clinical validation and regulatory approvals domestically and internationally. Corologic's AngioFilm technology uses AI-based video frame interpolation to reduce radiation exposure during coronary angiography procedures. The solution can integrate with existing angiography equipment without replacement, offering low adoption burden for healthcare providers.
Who to call at Corologic, and when
A new round usually means Corologic is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Corologic raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Corologic, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Corologic. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Corologic raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Corologic raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.